Press Releases

Oct 29, 2015

Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2015 Financial Results on Thursday, November 5, 2015

Read More

Oct 21, 2015

Veracyte Presents New Data on Gene Variants and Fusions In Thyroid Cancer Diagnosis

Read More

Oct 21, 2015

Two New Studies Demonstrate the Long-Term Clinical Utility of Veracyte's Afirma® Gene Expression Classifier in Safely Reducing Unnecessary Thyroid Surgeries

Read More

Oct 20, 2015

Veracyte Announces Data Supporting Use of the Percepta™ Bronchial Genomic Classifier to Be Presented at CHEST 2015

Read More

Oct 19, 2015

Veracyte CEO Bonnie Anderson Urges CMS to Reverse Its Proposed 2016 Pricing Methodology for Advanced Molecular Diagnostic Tests

Read More

Oct 16, 2015

Veracyte Announces Data from Multiple Afirma® Gene Expression Classifier Studies to Be Presented at the 15th International Thyroid Congress

Read More

Oct 15, 2015

New American Thyroid Association Guidelines Include Recommendation for Veracyte's Afirma® Gene Expression Classifier to Rule Out Cancer in Indeterminate Thyroid Nodules

Read More

Sep 28, 2015

Veracyte Statement on CMS's Preliminary 2016 Clinical Laboratory Fee Schedule and Proposed PAMA Rule

Read More

Sep 14, 2015

Veracyte Announces Publication of New Long-Term Outcome Study that Reinforces the Clinical Utility of the Afirma® Gene Expression Classifier

Read More

Sep 09, 2015

Veracyte Announces Presentation of Percepta™ Bronchial Genomic Classifier Clinical Validation Data at the 16th World Conference on Lung Cancer

Read More